Nima Ghamsari, an officer and director of Blend Labs, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 25,511 shares of Blend Labs common stock through Charles Schwab & Co., Inc.

Key Highlights

  • Proposed sale: Ghamsari intends to sell 25,511 shares of Blend Labs common stock with an aggregate market value of $24,615.00, according to the filing.
  • Source of shares: The shares were acquired on November 20, 2025, through a restricted stock lapse from Blend Labs, Inc., with payment classified as equity compensation.
  • Shares outstanding: The filing lists 235,014,095 shares of Blend Labs common stock outstanding.
  • Trading plan: The notice indicates a Rule 10b5-1 plan was adopted on June 15, 2026.
  • Approximate sale date: The filing states an approximate sale date of November 9, 2026, executed through Charles Schwab & Co., Inc. on the NYSE.
  • Prior three-month sales: The filing discloses eight prior sales by Ghamsari between September 14, 2026, and November 2, 2026, totaling shares across those transactions with gross proceeds ranging from $23,903.00 to $25,784.00 per transaction.

Ghamsari's Rule 144 Notice: Proposed Sale and Recent Transaction History

According to the Form 144 filing dated November 9, 2026, Nima Ghamsari, who is identified as both an officer and a director of Blend Labs, Inc. (NYSE:BLND), proposes to sell 25,511 shares of common stock through Charles Schwab & Co., Inc., located at 3000 Schwab Way, Westlake, TX. The aggregate market value of the proposed sale is listed as $24,615.00. The filing indicates the shares to be sold were acquired on November 20, 2025, via a restricted stock lapse from Blend Labs, Inc., with the nature of payment described as equity compensation.

The filing also discloses that Ghamsari adopted a written trading plan under Rule 10b5-1 on June 15, 2026. Under that plan, the filing records eight sales in the three months preceding this notice. Those sales took place on September 14, September 21, September 28, October 5, October 12, October 19, October 26, and November 2, 2026. Share amounts per transaction ranged from 17,731 to 27,775, with gross proceeds per transaction ranging from $23,903.00 to $25,784.00, as disclosed in the filing.

The filing states that at the time of notice, 235,014,095 shares of Blend Labs common stock were outstanding. By signing the Form 144, Ghamsari represented, as of the plan adoption date, that he did not know any material adverse information regarding the current and prospective operations of Blend Labs that had not been publicly disclosed, as required by the form's attestation language.

What Was Disclosed

Nima Ghamsari, an officer and director of Blend Labs, Inc., filed a Form 144 notice proposing the sale of 25,511 common shares valued at $24,615.00, acquired via a restricted stock lapse, with an approximate sale date of November 9, 2026, under a Rule 10b5-1 plan adopted June 15, 2026.